TCL Archive As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data. October 22, 2004
TCL Archive FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer. July 27, 2007
TCL Archive Centers Subcommittee Kills Guidelines Proposal, Suggest Formula Ceiling On Core Grants January 6, 1978
TCL Archive ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated March 12, 1999
TCL Archive NCI Shakeup Possibilities Grow; Marc Lippman To Head Lombardi Center; DCT Could Lose CTEP March 11, 1988
